Crossmark

Real-world safety of deucravacitinib: insights from the Food and Drug Administration Adverse Event Reporting System

Published Online: 2025-04-09

Published Print: 2025-10

Authors

Zhao, Kaidi

Xiao, Shengxiang

Zhao, Yang

Tu, Chen https://orcid.org/0009-0002-1286-903X
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82003356)

Natural Science Foundation of Shaanxi Province (2019JQ-511)

Basic-Clinical Fusion Innovation Project of Xi’an Jiaotong University Medicine (YXJLRH2022095)
License Information

Text and Data Mining valid from 2025-04-09

Version of Record valid from 2025-04-09
More Information

Article History

Received: 18 October 2024

Accepted: 26 February 2025

First Online: 9 April 2025

Conflicts of interest

: The authors have no conflicts of interest to declare.

Document is current